The STAR*D project results: A comprehensive review of findings

Diane Warden, A. John Rush, Madhukar H. Trivedi, Maurizio Fava, Stephen R. Wisniewski

Research output: Contribution to journalArticle

334 Citations (Scopus)

Abstract

The Sequenced Treatment Alternatives to Relieve Depression trial enrolled outpatients with nonpsychotic major depressive disorder treated prospectively in a series of randomized controlled trials. These were conducted in representative primary and psychiatric practices. Remission rates for treatment steps 1 to 4 based on the 16-item Quick Inventory of Depressive Symptomatology-Self-report were 37%, 31%, 14%, and 13%, respectively. There were no differences in remission rates or times to remission among medication switch or among medication augmentation strategies at any treatment level. Participants who required increasing numbers of treatment steps showed greater depressive illness burden and increasingly greater relapse rates in the naturalistic follow-up period (40%-71%). Prognosis was better at all levels for participants who entered follow-up in remission as opposed to those who entered with response without remission. These results highlight the prevalence of treatment-resistant depression and suggest potential benefit for using more vigorous treatments in the earlier steps.

Original languageEnglish (US)
Pages (from-to)449-459
Number of pages11
JournalCurrent Psychiatry Reports
Volume9
Issue number6
DOIs
StatePublished - Dec 2007

Fingerprint

Treatment-Resistant Depressive Disorder
Therapeutics
Cost of Illness
Major Depressive Disorder
Self Report
Psychiatry
Outpatients
Randomized Controlled Trials
Depression
Recurrence
Equipment and Supplies

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

The STAR*D project results : A comprehensive review of findings. / Warden, Diane; Rush, A. John; Trivedi, Madhukar H.; Fava, Maurizio; Wisniewski, Stephen R.

In: Current Psychiatry Reports, Vol. 9, No. 6, 12.2007, p. 449-459.

Research output: Contribution to journalArticle

Warden, Diane ; Rush, A. John ; Trivedi, Madhukar H. ; Fava, Maurizio ; Wisniewski, Stephen R. / The STAR*D project results : A comprehensive review of findings. In: Current Psychiatry Reports. 2007 ; Vol. 9, No. 6. pp. 449-459.
@article{3218a69ad9d74c9aac2d38282fd029f8,
title = "The STAR*D project results: A comprehensive review of findings",
abstract = "The Sequenced Treatment Alternatives to Relieve Depression trial enrolled outpatients with nonpsychotic major depressive disorder treated prospectively in a series of randomized controlled trials. These were conducted in representative primary and psychiatric practices. Remission rates for treatment steps 1 to 4 based on the 16-item Quick Inventory of Depressive Symptomatology-Self-report were 37{\%}, 31{\%}, 14{\%}, and 13{\%}, respectively. There were no differences in remission rates or times to remission among medication switch or among medication augmentation strategies at any treatment level. Participants who required increasing numbers of treatment steps showed greater depressive illness burden and increasingly greater relapse rates in the naturalistic follow-up period (40{\%}-71{\%}). Prognosis was better at all levels for participants who entered follow-up in remission as opposed to those who entered with response without remission. These results highlight the prevalence of treatment-resistant depression and suggest potential benefit for using more vigorous treatments in the earlier steps.",
author = "Diane Warden and Rush, {A. John} and Trivedi, {Madhukar H.} and Maurizio Fava and Wisniewski, {Stephen R.}",
year = "2007",
month = "12",
doi = "10.1007/s11920-007-0061-3",
language = "English (US)",
volume = "9",
pages = "449--459",
journal = "Current Psychiatry Reports",
issn = "1523-3812",
publisher = "Current Science, Inc.",
number = "6",

}

TY - JOUR

T1 - The STAR*D project results

T2 - A comprehensive review of findings

AU - Warden, Diane

AU - Rush, A. John

AU - Trivedi, Madhukar H.

AU - Fava, Maurizio

AU - Wisniewski, Stephen R.

PY - 2007/12

Y1 - 2007/12

N2 - The Sequenced Treatment Alternatives to Relieve Depression trial enrolled outpatients with nonpsychotic major depressive disorder treated prospectively in a series of randomized controlled trials. These were conducted in representative primary and psychiatric practices. Remission rates for treatment steps 1 to 4 based on the 16-item Quick Inventory of Depressive Symptomatology-Self-report were 37%, 31%, 14%, and 13%, respectively. There were no differences in remission rates or times to remission among medication switch or among medication augmentation strategies at any treatment level. Participants who required increasing numbers of treatment steps showed greater depressive illness burden and increasingly greater relapse rates in the naturalistic follow-up period (40%-71%). Prognosis was better at all levels for participants who entered follow-up in remission as opposed to those who entered with response without remission. These results highlight the prevalence of treatment-resistant depression and suggest potential benefit for using more vigorous treatments in the earlier steps.

AB - The Sequenced Treatment Alternatives to Relieve Depression trial enrolled outpatients with nonpsychotic major depressive disorder treated prospectively in a series of randomized controlled trials. These were conducted in representative primary and psychiatric practices. Remission rates for treatment steps 1 to 4 based on the 16-item Quick Inventory of Depressive Symptomatology-Self-report were 37%, 31%, 14%, and 13%, respectively. There were no differences in remission rates or times to remission among medication switch or among medication augmentation strategies at any treatment level. Participants who required increasing numbers of treatment steps showed greater depressive illness burden and increasingly greater relapse rates in the naturalistic follow-up period (40%-71%). Prognosis was better at all levels for participants who entered follow-up in remission as opposed to those who entered with response without remission. These results highlight the prevalence of treatment-resistant depression and suggest potential benefit for using more vigorous treatments in the earlier steps.

UR - http://www.scopus.com/inward/record.url?scp=37349044684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349044684&partnerID=8YFLogxK

U2 - 10.1007/s11920-007-0061-3

DO - 10.1007/s11920-007-0061-3

M3 - Article

C2 - 18221624

AN - SCOPUS:37349044684

VL - 9

SP - 449

EP - 459

JO - Current Psychiatry Reports

JF - Current Psychiatry Reports

SN - 1523-3812

IS - 6

ER -